HRD Insight - Exact Check - Home Service

Find best HRD Insight price (in Home Service) by Exact Check. Homologous Recombination Deficiency testing is essential for personalizing treatment for ovarian cancer. This test identifies tumors that have impaired DNA repair mechanisms, which is critical for determining the best treatment options for patients. Specifically, those with HRD-positive tumors, which may include patients with BRCA1/2 mutations, are likely to benefit from targeted therapies such as PARP inhibitors. By using HRD Insight testing, oncologists can create tailored treatment plans that improve patient outcomes and reduce the risk of unnecessary side effects. The HRD Insight test is available as a home service in select areas of Metro Manila, including Quezon City, San Juan City, Mandaluyong City, Manila City, Caloocan City, Pasig City, and Marikina City. For home service, a minimum test cost of ₱500 is required, with an additional service fee ranging from ₱600 to ₱700. This accessibility ensures that more patients can receive critical testing without needing to travel, ultimately enhancing the management of ovarian cancer.